PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9683930-6	1998	AII concentration- and time-dependently increased expression of thrombin receptor mRNA in VMSC and augmented the thrombin-induced release of 6-keto-prostaglandin F1 alpha as well as the thrombin induced contraction.	6-Ketoprostaglandin F1 alpha	141-170	angiotensinogen	Rattus norvegicus	0-3	
4030047-4	1985	Administration of norepinephrine (1-10 nmol), arginine vasopressin (0.03-0.3 nmol), or angiotensin II (0.1-1 nmol) produced vasoconstriction and increased the output of 6-keto-prostaglandin F1 alpha and prostaglandin E2 in a dose-related manner in mesenteric vessels.	6-Ketoprostaglandin F1 alpha	169-198	angiotensinogen	Rattus norvegicus	87-101	
9097077-8	1997	Ang II and Ang-(2-8) also released prostacyclin from medullary and cerebellar astrocytes, measured as the release of its stable metabolite 6-keto-PGF1 alpha.	6-Ketoprostaglandin F1 alpha	139-156	angiotensinogen	Rattus norvegicus	0-6	
9116917-7	1997	Both propranolol and RHC-80267 inhibited the Ang II-induced synthesis of 6-keto-prostaglandin F1 alpha, a stable metabolite of prostacyclin.	6-Ketoprostaglandin F1 alpha	73-102	angiotensinogen	Rattus norvegicus	45-51	
6689628-1	1983	The effect of Angiotensin II (A-II) on 6-keto-prostaglandin F1 (6-keto-PGF1 alpha) and prostaglandin F (PGF) production by the rat uterus was studied using a novel superfusion technique.	6-Ketoprostaglandin F1 alpha	64-81	angiotensinogen	Rattus norvegicus	14-28	
3917874-3	1985	Administration of angiotensin II (0.028-0.28 nmol) or bradykinin (0.28-2.8 nmol) enhanced the output of prostaglandin E2 and 6-keto-prostaglandin F1 alpha in a dose-dependent manner.	6-Ketoprostaglandin F1 alpha	125-154	angiotensinogen	Rattus norvegicus	18-32	
6689628-1	1983	The effect of Angiotensin II (A-II) on 6-keto-prostaglandin F1 (6-keto-PGF1 alpha) and prostaglandin F (PGF) production by the rat uterus was studied using a novel superfusion technique.	6-Ketoprostaglandin F1 alpha	64-81	angiotensinogen	Rattus norvegicus	30-34	
6689628-4	1983	In uterine horns from castrated, estrogen treated rats, A-II (10(-6)M) stimulated the production rate of 6-keto-PGF1 alpha in the myometrium nd PGF in the endometrium.	6-Ketoprostaglandin F1 alpha	105-122	angiotensinogen	Rattus norvegicus	56-60	
6575977-5	1983	Relative to a control value of 129 +/- 12 pg/ml in vehicle-infused (V) rats, arterial plasma 6-keto-PGF1 alpha concentration increased by 133% (P less than 0.01) with AII infusion.	6-Ketoprostaglandin F1 alpha	93-110	angiotensinogen	Rattus norvegicus	167-170	
6575977-6	1983	Aortic rings from AII-infused rats released more 6-keto-PGF1 alpha (68 +/- 7 ng/mg) during 15-min incubation in Krebs solution than did rings from V rats (40 +/- 3 ng/mg); release of PGE2, which was less than 1% of that of 6-keto-PGF1 alpha, was also increased.	6-Ketoprostaglandin F1 alpha	49-66	angiotensinogen	Rattus norvegicus	18-21	
6575977-6	1983	Aortic rings from AII-infused rats released more 6-keto-PGF1 alpha (68 +/- 7 ng/mg) during 15-min incubation in Krebs solution than did rings from V rats (40 +/- 3 ng/mg); release of PGE2, which was less than 1% of that of 6-keto-PGF1 alpha, was also increased.	6-Ketoprostaglandin F1 alpha	223-240	angiotensinogen	Rattus norvegicus	18-21	
6575977-7	1983	Slices of inner renal medulla from AII-infused rats released more 6-keto-PGF1 alpha (14 +/- 1 ng/mg) during incubation than did slices from V rats (8 +/- 1 ng/mg, P less than 0.05), but PGE2 release was not altered.	6-Ketoprostaglandin F1 alpha	66-83	angiotensinogen	Rattus norvegicus	35-38